Skip to content

Assessment of diaphragm function and ventilator withdrawal in neurogenic respiratory failure guided by shear wave elastography

Assessment of diaphragm function and ventilator withdrawal in neurogenic respiratory failure guided by shear wave elastography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104352
Enrollment
Unknown
Registered
2025-06-16
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurogenic respiratory failure

Interventions

Experimental group :nothing
Control group:nothing

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The age of 18 years old and above, male or female; 2.Craniocerebral injury, intracranial infection, cerebrovascular disease, peripheral nerve or muscle disease and other neurogenic diseases leading to ventilator withdrawal difficulties were diagnosed as neurogenic respiratory failure; 3.Need to rely on ventilators to maintain respiratory function, continuous use of ventilators for more than 48 hours; 4.No serious heart, liver, kidney and other organ dysfunction, no serious infection, bleeding, tumor and other complications; 5.No contraindications or allergic reactions to ultrasound or shear-elastography; 6.Volunteer to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.The patients with serious lung disease or cardiovascular disease; 2.Respiratory failure caused by other causes such as lung disease, thoracic deformity, etc.; 3.There are structural or functional abnormalities of the diaphragm or other respiratory muscles, such as diaphragmatic hiatus hernia, muscular dystrophy, etc.; 4.There are factors that affect the results of shear elastography, such as ascites, pneumothorax, pleural effusion, etc; 5.Vital signs fluctuate, may be further aggravated life-threatening; 6.Serious adverse events occurred during the study period, such as cardiac arrest, respiratory arrest, shock, etc. 7.During the study period, the participant voluntarily withdrew or was terminated by the researcher.

Design outcomes

Primary

MeasureTime frame
shear wave velocity;Young modulus;

Countries

China

Contacts

Public ContactWang Zhiqiang

The First Affiliated Hospital of Fujian Medical University

wzhq1992@163.com+86 138 0505 9300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026